Suppr超能文献

比哌立登对映体对毒蕈碱受体亚型的亲和力和选择性。

Affinity and selectivity of biperiden enantiomers for muscarinic receptor subtypes.

作者信息

Eltze M, Figala V

机构信息

Department of Pharmacology, Byk Gulden Pharmaceuticals, Konstanz, F.R.G.

出版信息

Eur J Pharmacol. 1988 Dec 6;158(1-2):11-9. doi: 10.1016/0014-2999(88)90247-6.

Abstract

The affinity of both the (+)- and the (-)-stereoisomer of biperiden for different muscarinic receptor subtypes was investigated in vitro in functional studies with field-stimulated rabbit vas deferens (M1-receptor), guinea-pig ileum (smooth muscle M2 beta-receptor) and rat left atrium (cardiac M2 alpha-receptor). (+)-Biperiden had its highest affinity to M1-receptors (pA2 = 9.07), had low affinity to cardiac M2 alpha-receptors (pA2 = 7.25) and intermediate affinity to ileal M2 beta-receptors (pA2 = 8.27). The ability of (+)-biperiden to discriminate between ileal M2 beta- and cardiac M2 alpha-receptors (factor = 10) was similar to that of 4-diphenylacetoxy-N-methylpiperidine methiodide (4-DAMP, factor = 9). In contrast, (-)-biperiden displayed low but nearly undistinguishable affinity for all muscarinic receptor subtypes studied (pA2 = 5.59 +/- 6.38). (+)-Biperiden discriminated strongly between M1- and cardiac M2 alpha-receptors (factor 66), thus being even more selective than pirenzepine (factor 28) which makes it one of the most M1-/cardiac M2 alpha-selective antimuscarinic drugs now available. These results indicate that (+)-biperiden could represent a further valuable tool for the characterization of muscarinic receptor subtypes.

摘要

在离体实验中,运用电刺激兔输精管(M1受体)、豚鼠回肠(平滑肌M2β受体)和大鼠左心房(心脏M2α受体)的功能研究方法,考察了比哌立登(biperiden)的(+)-和(-)-立体异构体对不同毒蕈碱受体亚型的亲和力。(+)-比哌立登对M1受体具有最高亲和力(pA2 = 9.07),对心脏M2α受体亲和力较低(pA2 = 7.25),对回肠M2β受体的亲和力处于中等水平(pA2 = 8.27)。(+)-比哌立登区分回肠M2β受体和心脏M2α受体的能力(区分因子 = 10)与4-二苯基乙酰氧基-N-甲基哌啶甲基碘化物(4-DAMP,区分因子 = 9)相似。相比之下,(-)-比哌立登对所研究的所有毒蕈碱受体亚型均显示出低亲和力,但几乎无明显差异(pA2 = 5.59 ± 6.38)。(+)-比哌立登对M1受体和心脏M2α受体有很强的区分能力(区分因子为66),因此其选择性甚至高于哌仑西平(区分因子为28),这使其成为目前最具M1/心脏M2α选择性的抗毒蕈碱药物之一。这些结果表明,(+)-比哌立登可能是进一步表征毒蕈碱受体亚型的有价值工具。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验